Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
- PMID: 16516152
- DOI: 10.1016/j.bbrc.2006.02.032
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
Abstract
The biochemical differences between simple steatosis, a benign liver disease, and non-alcoholic steatohepatitis, which leads to cirrhosis, are unclear. Fat aussie is an obese mouse strain with a truncating mutation (foz) in the Alms1 gene. Chow-fed female foz/foz mice develop obesity, diabetes, and simple steatosis. We fed foz/foz and wildtype mice a high-fat diet. Foz/foz mice developed serum ALT elevation and severe steatohepatitis with hepatocyte ballooning, inflammation, and fibrosis; wildtype mice showed simple steatosis. Biochemical pathways favoring hepatocellular lipid accumulation (fatty acid uptake; lipogenesis) and lipid disposal (fatty acid beta-oxidation; triglyceride egress) were both induced by high-fat feeding in wildtype but not foz/foz mice. The resulting extremely high hepatic triglyceride levels were associated with induction of mitochondrial uncoupling protein-2 and adipocyte-specific fatty acid binding protein-2, but not cytochrome P4502e1 or lipid peroxidation. In this model of metabolic syndrome, transition of steatosis to steatohepatitis was associated with hypoadiponectinemia, a mediator of hepatic fatty acid disposal pathways.
Similar articles
-
Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.J Gastroenterol Hepatol. 2009 Oct;24(10):1658-68. doi: 10.1111/j.1440-1746.2009.05996.x. J Gastroenterol Hepatol. 2009. PMID: 19788606
-
Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x. J Gastroenterol Hepatol. 2012. PMID: 21929649
-
Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.Obesity (Silver Spring). 2013 Jun;21(6):1189-99. doi: 10.1002/oby.20123. Epub 2013 May 10. Obesity (Silver Spring). 2013. PMID: 23666886
-
Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G194-8. doi: 10.1152/ajpgi.00413.2005. Am J Physiol Gastrointest Liver Physiol. 2006. PMID: 16407588 Review.
-
Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.Semin Liver Dis. 2008 Nov;28(4):407-26. doi: 10.1055/s-0028-1091985. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956297 Review.
Cited by
-
Western Diet Promotes Renal Injury, Inflammation, and Fibrosis in a Murine Model of Alström Syndrome.Nephron. 2020;144(8):400-412. doi: 10.1159/000508636. Epub 2020 Jul 6. Nephron. 2020. PMID: 32629454 Free PMC article.
-
Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease.Int J Med Sci. 2018 Oct 20;15(14):1591-1599. doi: 10.7150/ijms.27953. eCollection 2018. Int J Med Sci. 2018. PMID: 30588181 Free PMC article. Review.
-
Mouse Models of Liver Parenchyma Injuries and Regeneration.Front Cell Dev Biol. 2022 May 5;10:903740. doi: 10.3389/fcell.2022.903740. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35721478 Free PMC article. Review.
-
Alström syndrome: insights into the pathogenesis of metabolic disorders.Nat Rev Endocrinol. 2011 Feb;7(2):77-88. doi: 10.1038/nrendo.2010.210. Epub 2010 Dec 7. Nat Rev Endocrinol. 2011. PMID: 21135875 Review.
-
Mechanisms of NAFLD development and therapeutic strategies.Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2. Nat Med. 2018. PMID: 29967350 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases